title: Food labeling: health claims; plant sterol/stanol esters and coronary heart disease. Food and Drug Administration, HHS. Interim final rule.
abstract: The Food and Drug Administration (FDA) is authorizing the use, on food labels and in food labeling, of health claims on the association between plant sterol/stanol esters and reduced risk of coronary heart disease (CHD).  FDA is taking this action in response to a petition filed by Lipton (plant sterol esters petitioner) and a petition filed by McNeil Consumer Healthcare (plant stanol esters petitioner).  Based on the totality of publicly available evidence, the agency has concluded that plant sterol/stanol esters may reduce the risk of CHD.
mesh_terms: D003327:Coronary Disease / Q000188:drug therapy*; D005515:Food Labeling / Q000331:legislation & jurisprudence; D006801:Humans; D006937:Hypercholesterolemia / Q000517:prevention & control; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D010840:Phytosterols / Q000627:therapeutic use*; D012307:Risk Factors; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000960:Hypolipidemic Agents; D010840:Phytosterols